About Medusa Therapeutics Limited
Medusa Therapeutics LimitedMTx is a HK-based start-up biotech company that develops first-in-class, first-in-industry drug discovery technology and small molecule drugs. MTx pioneers in the field of liquid-liquid phase separated biomolecular condensate-targeted drugs (condensate drugs). MTx’ founders have recently published their findings describing the first small molecule capable of inhibiting a functional condensate resulting in a therapeutic effect in an animal model of Respiratory Syncytial Virus (Risso-Ballester, Nature, 2021).
